Lv4
480 积分 2020-10-12 加入
How I use maintenance therapy in acute myeloid leukemia
10天前
已完结
How I treat secondary acute myeloid leukemia
10天前
已完结
How I treat acute myeloid leukemia with differentiation therapy
10天前
已完结
How I treat patients with AML using azacitidine and venetoclax
15天前
已完结
Clinical-genomic profiling of MDS to inform allo-HSCT:Recommendations from an international panel on behalf of the EBMT
1个月前
已关闭
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
2个月前
已关闭
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes
2个月前
已关闭
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
2个月前
已完结
Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia
2个月前
已完结
How I Treat AML relapse after allogeneic HCT
2个月前
已完结
皖公网安备34019202002308
